279 related articles for article (PubMed ID: 34884669)
1. Microsatellite Instability Analysis (MSA) for Bladder Cancer: Past History and Future Directions.
Moon C; Gordon M; Moon D; Reynolds T
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884669
[TBL] [Abstract][Full Text] [Related]
2. Qualification of the Microsatellite Instability Analysis (MSA) for Bladder Cancer Detection: The Technical Challenges of Concordance Analysis.
Reynolds T; Bertsche K; Moon D; Moon C
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203379
[TBL] [Abstract][Full Text] [Related]
3. [Microsatellite analysis in exfoliated cells from urinary sediment. Its utility for the detection of bladder cancer. Comparison with urinary cytology].
Molina Burgos R; Millán Salvador JM; Oltra Soler JS; Jiménez Cruz JF
Actas Urol Esp; 2003 Sep; 27(8):618-28. PubMed ID: 14587237
[TBL] [Abstract][Full Text] [Related]
4. [Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value].
Lü Y; Tang D; Yu L; Ding Y; Liu L; Guo Y
Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):294-6. PubMed ID: 12828175
[TBL] [Abstract][Full Text] [Related]
5. Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine.
Seripa D; Parrella P; Gallucci M; Gravina C; Papa S; Fortunato P; Alcini A; Flammia G; Lazzari M; Fazio VM
Int J Cancer; 2001 Nov; 95(6):364-9. PubMed ID: 11668518
[TBL] [Abstract][Full Text] [Related]
6. Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder.
Mourah S; Cussenot O; Vimont V; Desgrandchamps F; Teillac P; Cochant-Priollet B; Le Duc A; Fiet J; Soliman H
Int J Cancer; 1998 Dec; 79(6):629-33. PubMed ID: 9842973
[TBL] [Abstract][Full Text] [Related]
7. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder.
Turyn J; Matuszewski M; Schlichtholz B
Oncol Rep; 2006 Jan; 15(1):259-65. PubMed ID: 16328066
[TBL] [Abstract][Full Text] [Related]
8. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
[TBL] [Abstract][Full Text] [Related]
9. Urinary markers in the everyday diagnosis of bladder cancer.
Dal Moro F; Valotto C; Guttilla A; Zattoni F
Urologia; 2013; 80(4):265-75. PubMed ID: 24419920
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive molecular detection of bladder cancer recurrence.
Amira N; Mourah S; Rozet F; Teillac P; Fiet J; Aubin P; Cortesse A; Desgrandchamps F; Le Duc A; Cussenot O; Soliman H
Int J Cancer; 2002 Sep; 101(3):293-7. PubMed ID: 12209982
[TBL] [Abstract][Full Text] [Related]
11. Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
Herman MP; Svatek RS; Lotan Y; Karakiewizc PI; Shariat SF
Minerva Urol Nefrol; 2008 Dec; 60(4):217-35. PubMed ID: 18923359
[TBL] [Abstract][Full Text] [Related]
12. [Non-invasive urinary diagnosis of bladder cancer. What do we know?].
Kausch I; Böhle A
Urologe A; 2003 Jul; 42(7):912-21. PubMed ID: 12898034
[TBL] [Abstract][Full Text] [Related]
13. MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass.
Fraune C; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kähler C; Kluth M; Höflmayer D; Büscheck F; Dum D; Luebke AM; Burandt E; Clauditz TS; Wilczak W; Sauter G; Steurer S
Urol Oncol; 2020 May; 38(5):488-495. PubMed ID: 32067846
[TBL] [Abstract][Full Text] [Related]
14. Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
Catto JW; Azzouzi AR; Amira N; Rehman I; Feeley KM; Cross SS; Fromont G; Sibony M; Hamdy FC; Cussenot O; Meuth M
Oncogene; 2003 Nov; 22(54):8699-706. PubMed ID: 14647464
[TBL] [Abstract][Full Text] [Related]
15. Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer.
Zhang R; Zang J; Xie F; Zhang Y; Wang Y; Jing Y; Zhang Y; Chen Z; Shahatiaili A; Cai MC; Zhao Z; Du P; Jia S; Zhuang G; Chen H
J Urol; 2021 Oct; 206(4):873-884. PubMed ID: 34061567
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemistry for ARID1A as a potential biomarker in urine cytology of bladder cancer.
Dugas SG; Müller DC; Le Magnen C; Federer-Gsponer J; Seifert HH; Ruiz C; Savic Prince S; Vlajnic T; Zellweger T; Mertz KD; Bacon JVW; Wyatt AW; Rentsch CA; Bubendorf L
Cancer Cytopathol; 2019 Sep; 127(9):578-585. PubMed ID: 31386310
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of microsatellite instability in urine for the diagnosis of transitional cell carcinoma of the lower urinary tract in dogs.
Sotirakopoulos AJ; Armstrong PJ; Heath L; Madrill NJ; McNiel EA
J Vet Intern Med; 2010; 24(6):1445-51. PubMed ID: 21039871
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.
Gilbert SM; Veltri RW; Sawczuk A; Shabsigh A; Knowles DR; Bright S; O'Dowd GJ; Olsson CA; Benson MC; Sawczuk IS
Urology; 2003 Mar; 61(3):539-43. PubMed ID: 12639642
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue.
Berger AP; Parson W; Stenzl A; Steiner H; Bartsch G; Klocker H
Eur Urol; 2002 May; 41(5):532-9. PubMed ID: 12074795
[TBL] [Abstract][Full Text] [Related]
20. Infrequent microsatellite instability in urothelial cell carcinoma of the bladder in young patients.
Mongiat-Artus P; Miquel C; van der Aa M; Buhard O; Hamelin R; Bangma C; Teillac P; van der Kwast T; Praz F
Eur Urol; 2006 Apr; 49(4):685-90. PubMed ID: 16413104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
